Recursion is at the leading edge of applying AI and ML to drug development. The company exemplifies a new wave of “techbio” companies, that tightly couple compute and robotics with biology and chemistry. The task of decoding biology requires vast amounts of biological data and innovative strategies to make use of that data. It also requires close coordination between experts across a wide range of domains – from software to cell biology.
Imran Haque is the SVP of AI and Digital Sciences and
Jordan Christensen is the SVP of Technology at
Recursion. They join the show today to talk about the unique data engineering challenges in biology, the growing importance of automation, reshaping the drug discovery funnel, their partnership with NVIDIA, and much more.
![]()
Sean’s been an academic, startup founder, and Googler. He has published works covering a wide range of topics from information visualization to quantum computing. Currently, Sean is Head of Marketing and Developer Relations at Skyflow and host of the podcast Partially Redacted, a podcast about privacy and security engineering. You can connect with Sean on Twitter @seanfalconer .
Â
The post Biotech Special: ML at Recursion with Jordan Christensen and Imran Haque appeared first on Software Engineering Daily.
